Follicular thyroid carcinoma but not adenoma recruits tumor-associated macrophages by releasing CCL15

被引:17
|
作者
Huang, Feng-Jiao [1 ,2 ]
Zhou, Xiao-Yi [1 ,2 ]
Ye, Lei [1 ,2 ]
Fei, Xiao-Chun [3 ]
Wang, Shu [1 ,2 ,4 ,5 ]
Wang, Weiqing [1 ,2 ]
Ning, Guang [1 ,2 ,4 ,5 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med,Shanghai Key Lab Endocrine Tumors, Shanghai Clin Ctr Endocrine & Metab Dis,Shanghai, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai E Inst Endocrinol, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pathol, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Lab Endocrine & Metab Dis, 227 South Chongqing Rd, Shanghai 200025, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, 227 South Chongqing Rd, Shanghai 200025, Peoples R China
来源
BMC CANCER | 2016年 / 16卷
基金
美国国家科学基金会;
关键词
Follicular thyroid carcinoma; Follicular adenoma; Tumor-associated macrophages; CCL15; COLONY-STIMULATING FACTOR; CCR1(+) MYELOID CELLS; LYMPH-NODE METASTASIS; DIFFERENTIAL-DIAGNOSIS; CANCER; EXPRESSION; PROGRESSION; PROMOTE; MICROENVIRONMENT; CLASSIFICATION;
D O I
10.1186/s12885-016-2114-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The differential diagnosis of follicular thyroid carcinoma (FTC) and follicular adenoma (FA) before surgery is a clinical challenge. Many efforts have been made but most focusing on tumor cells, while the roles of tumor associated macrophages (TAMs) remained unclear in FTC. Here we analyzed the differences between TAMs in FTC and those in FA. Methods: We first analyzed the density of TAMs by CD68 immunostaining in 59 histologically confirmed FTCs and 47 FAs. Cytokines produced by FTC and FA were profiled using antibody array, and validated by quantitative PCR. Chemotaxis of monocyte THP-1 was induced by condition medium of FTC cell lines (FTC133 and WRO82-1) with and without anti-CCL15 neutralizing antibody. Finally, we analyzed CCL15 protein level in FTC and FA by immunohistochemistry. Results: The average density of CD68(+) cells was 9.5 +/- 5.4/field in FTC, significantly higher than that in FA (4.9 +/- 3.4/field, p < 0.001). Subsequently profiling showed that CCL15 was the most abundant chemokine in FTC compared with FA. CCL15 mRNA in FTC was 51.4-folds of that in FA. CM of FTC cell lines induced THP-1 cell chemotaxis by 33 similar to 77 %, and anti-CCL15 neutralizing antibody reduced THP-1 cell migration in a dose-dependent manner. Moreover, we observed positive CCL15 immunostaining in 67.8 % of FTCs compared with 23.4 % of FAs. Conclusion: Our study suggested FTC might induce TAMs infiltration by producing CCL15. Measurement of TAMs and CCL15 in follicular thyroid lesions may be applied clinically to differentiate FTC from FA pre-operation.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma
    Carl Ludwig Behnes
    Felix Bremmer
    Bernhard Hemmerlein
    Arne Strauss
    Philipp Ströbel
    Heinz-Joachim Radzun
    Virchows Archiv, 2014, 464 : 191 - 196
  • [42] Characterizing tumor-associated macrophages in the cutaneous squamous cell carcinoma tumor microenvironment
    Mittal, A.
    Vidyarthi, A.
    Colegio, O.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : B9 - B9
  • [43] Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma
    Behnes, Carl Ludwig
    Bremmer, Felix
    Hemmerlein, Bernhard
    Strauss, Arne
    Stroebel, Philipp
    Radzun, Heinz-Joachim
    VIRCHOWS ARCHIV, 2014, 464 (02) : 191 - 196
  • [44] CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer
    Lin, Ling
    Chen, Yong-Song
    Yao, Yan-Dan
    Chen, Jing-Qi
    Chen, Jia-Ning
    Huang, Song-Yin
    Zeng, Yun-Jie
    Yao, He-Rui
    Zeng, Si-Hai
    Fu, Yong-Shui
    Song, Er-Wei
    ONCOTARGET, 2015, 6 (33) : 34758 - 34773
  • [45] Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
    Bulle, Ashenafi
    Dekervel, Jeroen
    Deschuttere, Lise
    Nittner, David
    Libbrecht, Louis
    Janky, Rekin's
    Plaisance, Stephane
    Topal, Baki
    Coosemans, An
    Lambrechts, Diether
    Van Cutsem, Eric
    Verslype, Chris
    van Pelt, Jos
    TRANSLATIONAL ONCOLOGY, 2020, 13 (03):
  • [46] Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
    Ryder, Mabel
    Ghossein, Ronald A.
    Ricarte-Filho, Julio C. M.
    Knauf, Jeffrey A.
    Fagin, James A.
    ENDOCRINE-RELATED CANCER, 2008, 15 (04) : 1069 - 1074
  • [47] Significance of CD204 positive tumor-associated macrophages in carcinogenesis of colorectal adenoma
    Taniyama, Daiki
    Taniyama, Kiyomi
    Zaitsu, Junichi
    Yamamoto, Hideki
    Saito, Akihisa
    Kuraoka, Kazuya
    Sakamoto, Naoya
    Sentani, Kazuhiro
    Oue, Naohide
    Yasui, Wataru
    CANCER SCIENCE, 2018, 109 : 1345 - 1345
  • [48] Significance of CD204 positive tumor-associated macrophages in carcinogenesis of colorectal adenoma
    Taniyama, Daiki
    Taniyama, Kiyomi
    Zaitsu, Junichi
    Saito, Akihisa
    Kuraoka, Kazuya
    Sakamoto, Naoya
    Sentani, Kazuhiro
    Oue, Naohide
    Yasui, Wataru
    CANCER SCIENCE, 2018, 109 : 676 - 676
  • [49] Tumor-Associated Macrophages Support Tumor Growth, Invasiveness and Angiogenesis in Papillary Thyroid Carcinoma Via CXCL16 Signaling
    Cho, Sun Wook
    Sun, Hyun Jin
    Kim, Young A.
    Han, Sun Kyoung
    Oh, Byung-Chul
    Yi, Ka Hee
    Park, Do Joon
    Park, Young Joo
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [50] Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17
    Zhang, Anke
    Xu, Yuanzhi
    Xu, Houshi
    Ren, Jie
    Meng, Tong
    Ni, Yunjia
    Zhu, Qingwei
    Zhang, Wen-Bo
    Pan, Yuan-Bo
    Jin, Jiali
    Bi, Yunke
    Wu, Zhe Bao
    Lin, Shaojian
    Lou, Meiqing
    THERANOSTICS, 2021, 11 (08): : 3839 - 3852